Matsuo Takahiro, Hayashi Kuniyoshi, Uehara Yuki, Mori Nobuyoshi
Department of Infectious Diseases, St. Luke's International Hospital, Tokyo, Japan.
Graduate School of Public Health, St. Luke's International University, Tokyo, Japan.
Open Forum Infect Dis. 2020 Oct 19;8(1):ofaa504. doi: 10.1093/ofid/ofaa504. eCollection 2021 Jan.
(SA) is the most common causative microorganism in native vertebral osteomyelitis (NVO). Few studies have compared the clinical features of NVO due to SA (SA-NVO) and NVO due to other organisms (NSA-NVO). This study was conducted to validate a predictive score for SA-NVO to facilitate NVO treatment without broad-spectrum antimicrobial agents.
This retrospective study compared the clinical features of patients with SA-NVO and NSA-NVO who were diagnosed from 2004 to 2019. Univariate associations were assessed using χ , Fisher's exact, or Mann-Whitney test. Multivariable analysis was conducted using logistic regression. The optimal age cutoff point was determined by classification and regression tree analysis.
Among 155 NVO patients, 98 (63.2%) had a microbiologically confirmed diagnosis: 40 (25.8%) with SA-NVO and 58 (37.4%) with NSA-NVO. Six predictors, either independently associated with SA-NVO or clinically relevant, were used to develop the STAPH prediction score: atopic dermatitis (Skin) (3 points); recent Trauma (2 points); Age < 67 years (1 point); Abscess (1 point); central venous Port catheter (2 points); and History of puncture (2 points). In a receiver operating characteristic analysis, the area under the curve was 0.84 (95% confidence interval, 0.76-0.91). The best cutoff point was 3. A score ≥3 had a sensitivity, specificity, positive predictive value, and negative predictive value of 58%, 84%, 84%, and 73%, respectively.
The STAPH score has relatively high specificity for use by clinicians to predict SA as the causative microorganism in patients with NVO until results of a confirmatory culture are available.
金黄色葡萄球菌(SA)是原发性椎体骨髓炎(NVO)最常见的致病微生物。很少有研究比较由SA引起的NVO(SA-NVO)和由其他微生物引起的NVO(非SA-NVO)的临床特征。本研究旨在验证SA-NVO的预测评分,以便在不使用广谱抗菌药物的情况下促进NVO的治疗。
这项回顾性研究比较了2004年至2019年诊断出的SA-NVO和非SA-NVO患者的临床特征。使用χ²检验、Fisher精确检验或Mann-Whitney检验评估单变量关联。使用逻辑回归进行多变量分析。通过分类和回归树分析确定最佳年龄分界点。
在155例NVO患者中,98例(63.2%)有微生物学确诊诊断:40例(25.8%)为SA-NVO,58例(37.4%)为非SA-NVO。使用六个与SA-NVO独立相关或具有临床相关性的预测因素来制定STAPH预测评分:特应性皮炎(皮肤)(3分);近期创伤(2分);年龄<67岁(1分);脓肿(1分);中心静脉导管(2分);以及穿刺史(2分)。在受试者工作特征分析中,曲线下面积为0.84(95%置信区间,0.76-0.91)。最佳分界点为3分。评分≥3分时,敏感性、特异性、阳性预测值和阴性预测值分别为58%、84%、84%和73%。
在获得确诊培养结果之前,STAPH评分对临床医生预测NVO患者中SA作为致病微生物具有较高的特异性。